These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1680895)

  • 1. The value of assays in tricyclic antidepressant therapy.
    Clower CG
    Indiana Med; 1991 Aug; 84(8):550-2. PubMed ID: 1680895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tricyclic antidepressant-induced seizures and plasma drug concentration.
    Preskorn SH; Fast GA
    J Clin Psychiatry; 1992 May; 53(5):160-2. PubMed ID: 1592842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral and cognitive toxicity related to elevated plasma tricyclic antidepressant levels.
    Meador-Woodruff JH; Akil M; Wisner-Carlson R; Grunhaus L
    J Clin Psychopharmacol; 1988 Feb; 8(1):28-32. PubMed ID: 3350996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tricyclic antidepressant plasma level monitoring: an improvement over the dose-response approach.
    Preskorn SH
    J Clin Psychiatry; 1986 Jan; 47(1 Suppl):24-30. PubMed ID: 2867088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tricyclic antidepressants: the whys and hows of therapeutic drug monitoring.
    Preskorn SH
    J Clin Psychiatry; 1989 Jul; 50 Suppl():34-42; discussion 43-6. PubMed ID: 2661550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacological treatment of delusional depression].
    Amore M; Giordani L; Giorgetti G; Zazzeri N
    Minerva Psichiatr; 1996 Mar; 37(1):29-33. PubMed ID: 8804200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Augmentation strategies with tricyclic or fluoxetine treatment in seven partially responsive panic disorder patients.
    Tiffon L; Coplan JD; Papp LA; Gorman JM
    J Clin Psychiatry; 1994 Feb; 55(2):66-9. PubMed ID: 8077156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quetiapine cross-reactivity with plasma tricyclic antidepressant immunoassays.
    Caravati EM; Juenke JM; Crouch BI; Anderson KT
    Ann Pharmacother; 2005 Sep; 39(9):1446-9. PubMed ID: 16046487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic drug monitoring of tricyclic antidepressants: how does it work under clinical conditions?
    Müller MJ; Dragicevic A; Fric M; Gaertner I; Grasmäder K; Härtter S; Hermann E; Kuss HJ; Laux G; Oehl W; Rao ML; Rollmann N; Weigmann H; Weber-Labonte M; Hiemke C
    Pharmacopsychiatry; 2003 May; 36(3):98-104. PubMed ID: 12806567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic drug monitoring for antidepressants: efficacy, safety, and cost effectiveness.
    Preskorn SH; Fast GA
    J Clin Psychiatry; 1991 Jun; 52 Suppl():23-33. PubMed ID: 1904862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fluoxetine and tricyclic antidepressants: clinical tolerance in short-term combined administration].
    Bonin B; Bertschy G; Baumann P; Francois T; Vandel P; Vandel S; Sechter D; Bizouard P
    Encephale; 1996; 22(3):221-7. PubMed ID: 8767051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased plasma tricyclic antidepressant concentrations in two patients concurrently treated with fluoxetine.
    Downs JM; Downs AD; Rosenthal TL; Deal N; Akiskal HS
    J Clin Psychiatry; 1989 Jun; 50(6):226-7. PubMed ID: 2785987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of therapeutic drug monitoring of amitriptyline and genotyping on efficacy and safety of depression therapy].
    Ostapowicz A; Zejmo M; Wrześniewska J; Białecka M; Górnik W; Gawrońska-Szklarz B
    Psychiatr Pol; 2000; 34(4):595-605. PubMed ID: 11059259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical pharmacokinetics of tricyclic antidepressants Part II. Drug therapy monitoring].
    Szymura-Oleksiak J; Wasieczko A; Wyska E; Zieba A
    Psychiatr Pol; 1994; 28(1):17-26. PubMed ID: 8190816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antidepressive agents in the elderly].
    de Hooge JK
    Tijdschr Gerontol Geriatr; 1990 Dec; 21(6):259-67. PubMed ID: 1980385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of bupropion in tricyclic-resistant or intolerant patients.
    Stern WC; Harto-Truax N; Bauer N
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):148-52. PubMed ID: 6406447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tricyclic-induced electroencephalogram abnormalities and plasma drug concentrations.
    Preskorn SH; Othmer SC; Lai CW; Othmer E
    J Clin Psychopharmacol; 1984 Oct; 4(5):262-4. PubMed ID: 6436340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability of remission during tricyclic antidepressant continuation therapy for dysthymia.
    Kocsis JH; Friedman RA; Markowitz JC; Miller N; Gniwesch L; Bram J
    Psychopharmacol Bull; 1995; 31(2):213-6. PubMed ID: 7491370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Managing rapid metabolizers of antidepressants.
    Kraus RP; Diaz P; McEachran A
    Depress Anxiety; 1996-1997; 4(6):320-7. PubMed ID: 9166660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.